Glend Llandtada - Philippines

“The FDA’s fast-tracking of X-ray facility licensing is an important step to combat COVID-19.”

Glend Llandtada, Asia Actual Philippines

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Philippines FDA Alters Requirements for Radiation Licensing During COVID-19

Published on: December 17th, 2020

Interim Guidelines for the Conduct of Licensing Inspection for Radiation Facilities

The FDA has issued FDA Circular No. 2020-035, which pertains to Interim Guidelines for the Conduct of Licensing Inspection for Radiation Facilities. Under this Circular, any pending applications will be nullified, requiring new applications to be submitted. Below are the interim guidelines for the conduct of pre-licensing inspections of Health Physics teams of the CDRRHR of the FDA.

Note: This Circular shall take effect November 19th 2020

The following facilities applying use of radiation devices during COVID-19 measures:

  • Diagnostic X-ray Facilities
  • Therapeutic X-ray Facilities utilizing Medical Linear Accelerator
  • Dental X-ray Facilities
  • Industrial and Anti-Crime X-ray Facilities
  • Education and Research X-ray Facilities
  • Veterinary X-ray Facilities
  • Transportable X-ray Facilities
  • Magnetic Resonance Imaging Facilities

However, the FDA will resume pre-licensing inspections for Medical Linear Accelerators. This can be done either online or by virtual inspection. For other types of radiation facilities, authorization will be done using an interim radiation facility authorization process and will be verified with a post-licensing inspection when quarantine measures end.

Grow with US

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with any questions or support requests.

Blog Posts

Australia SaMD Transition Deadline

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia's Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.
Read more
Thai FDA Documentation Exemptions for Concise and Full Regulatory Pathways

Thai FDA Regulatory Documentation Exemptions

March 12, 2024: the Thai FDA released draft guidance updating the list of required documentation for Full and Concise Evaluation. For manufacturers registering a medical device in Thailand, certain documents are no longer required.
Read more
Hong Kong MDD adds Singapore HSA to Reference Country List

Hong Kong MDD Adds Singapore as Reference Country

Starting April 2nd, 2024, the Hong Kong Medical Device Division (MDD) accepts, on a regular basis, the marketing approvals obtained from the the Health Sciences Authority (HSA) of Singapore as a support of compliance of medical device to the "Essential Principles of Safety and Performance of Medical Devices" (Technical Reference: TR-004) under MDACS.
Read more